- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/26 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
Patent holdings for IPC class C07D 241/26
Total number of patents in this class: 137
10-year publication summary
|
6
|
11
|
7
|
13
|
5
|
12
|
9
|
17
|
8
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Medibeacon, Inc. | 136 |
17 |
| Novartis AG | 10882 |
11 |
| Astellas Pharma Inc. | 1088 |
7 |
| Parion Sciences, Inc. | 62 |
7 |
| Biomea Fusion, Inc. | 51 |
7 |
| Kotobuki Pharmaceutical Co., Ltd. | 38 |
4 |
| Mallinckrodt Inc. | 177 |
4 |
| Nippon Shinyaku Co., Ltd. | 332 |
4 |
| F. Hoffmann-La Roche AG | 7932 |
3 |
| AstraZeneca AB | 2924 |
3 |
| Syngenta Participations AG | 1908 |
3 |
| Takeda Pharmaceutical Company Limited | 2707 |
3 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
3 |
| Sentinel Oncology Limited | 38 |
3 |
| Valve Corporation | 603 |
3 |
| Viracta Therapeutics, Inc. | 29 |
3 |
| Hangzhou Zhongmeihuadong Pharmaceutical Co. Ltd. | 76 |
3 |
| The Regents of the University of California | 19859 |
2 |
| Syngenta Limited | 457 |
2 |
| Abbvie Inc. | 1803 |
2 |
| Other owners | 43 |